Search
for
Sort by
Research 61–90 of 114
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Rare and common genetic determinants of metabolic individuality and their effects on human health
- A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach
- Poster Presentations
- Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations
- Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Niosomes as Vesicular Nanocarriers in Cosmetics: Characterisation, Development and Efficacy
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Management of Dermatologic Toxicities
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Erosive Pustular Dermatosis: A Manifestation of Immunosenescence A Report of 8 Cases
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
- Efficacy and Safety of Cinobufacin Combined with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta‐Analysis
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Hair mass index obtained by cross-section trichometry: an objective and clinically useful parameter to quantify hair in chemotherapy-induced alopecia
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- Cancer-Related Alopecia: From Etiologies to Global Management
- Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel
- Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial
- Adaptive 3D Self‐Assembly of Colorectal Cancer Cells With Unchanged Tumor Phenotype and Drug Sensitivity
- Efficacy of albumin-bound paclitaxel combined with nedaplatin in neoadjuvant therapy for esophageal squamous cell carcinoma: A single-center retrospective observational study
- Erosive Pustular Dermatosis: Delving into Etiopathogenesis and Management